Personal view, short selling won’t be a big problem for FY21 and FY22. Obviously MYX is conservative about FDA approvals this time, as lessons learnt from last. Too risky to short when two big hits in the pipeline.
- Forums
- ASX - By Stock
- Ann: Change in substantial holding
Personal view, short selling won’t be a big problem for FY21 and...
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$4.47 |
Change
0.060(1.36%) |
Mkt cap ! $382.8M |
Open | High | Low | Value | Volume |
$4.43 | $4.54 | $4.42 | $953.7K | 213.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1280 | $4.69 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$4.16 | 216 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
12 | 3380 | 4.460 |
6 | 1563 | 4.450 |
10 | 11737 | 4.440 |
3 | 525 | 4.430 |
5 | 13867 | 4.420 |
Price($) | Vol. | No. |
---|---|---|
4.470 | 4 | 1 |
4.480 | 1322 | 12 |
4.490 | 3718 | 7 |
4.500 | 1199 | 5 |
4.510 | 3664 | 7 |
Last trade - 15.59pm 03/07/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO & MD
Anthony Noble
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online